Patents by Inventor Thomas David Reed

Thomas David Reed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apparatus configured to act as both an edger and a sod cutter
    Patent number: 10548252
    Abstract: Described herein is a combination apparatus and methods of using the combination apparatus. The combination apparatus is operable as both an edger and a sod cutter. The combination apparatus includes an arm that oscillates when driven by a motor. Both a sod cutter blade and an edger blade are coupled to the arm.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: February 4, 2020
    Inventor: Thomas David Reed
  • APPARATUS CONFIGURED TO ACT AS BOTH AN EDGER AND A SOD CUTTER
    Publication number: 20190069467
    Abstract: Described herein is a combination apparatus and methods of using the combination apparatus. The combination apparatus is operable as both an edger and a sod cutter. The combination apparatus includes an arm that oscillates when driven by a motor. Both a sod cutter blade and an edger blade are coupled to the arm.
    Type: Application
    Filed: November 5, 2018
    Publication date: March 7, 2019
    Inventor: Thomas David Reed
  • Apparatus configured to act as both an edger and a sod cutter
    Patent number: 10117372
    Abstract: Described herein is a combination apparatus and methods of using the combination apparatus. The combination apparatus is operable as both an edger and a sod cutter. The combination apparatus includes an arm that oscillates when driven by a motor. Both a sod cutter blade and an edger blade are coupled to the arm.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: November 6, 2018
    Inventor: Thomas David Reed
  • mTOR ligands and polynucleotides encoding mTOR ligands
    Patent number: 9301992
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: April 5, 2016
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • Polynucleotides encoding extracellular-signal-regulated kinase (ERK) heteropolyligand polypeptides
    Patent number: 9255125
    Abstract: The invention relates to kinase inhibitor ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate ERK activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: February 9, 2016
    Assignee: Intrexon Corporation
    Inventor: Thomas David Reed
  • mTOR Ligands and Polynucleotides Encoding mTOR Ligands
    Publication number: 20160022766
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: October 7, 2015
    Publication date: January 28, 2016
    Inventors: Thomas David REED, Amy H. Atzel
  • mTOR ligands and polynucleotides encoding mTOR ligands
    Patent number: 9181314
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: November 10, 2015
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • mTOR Ligands and Polynucleotides Encoding mTOR Ligands
    Publication number: 20150291676
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: June 25, 2015
    Publication date: October 15, 2015
    Applicant: Intrexon Corporation
    Inventors: Thomas David REED, Amy H. Atzel
  • mTOR ligands and polynucleotides encoding mTOR ligands
    Patent number: 9096680
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: February 24, 2014
    Date of Patent: August 4, 2015
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • Tubulo-vesicular structure localization signals
    Patent number: 8993742
    Abstract: The invention relates to polarized cell tubulo-vesicular structure localization signals. The localization signals are utilized as research tools or are linked to polypeptides of interest or therapeutic molecules. Disclosed are methods of making and using polypeptides and modified polypeptides as signals to localize therapeutics, experimental compounds, peptides, proteins and/or other macromolecules to the tubulo-vesicular structures of polarized cells. The polypeptides of the invention optionally include linkage to reporters, epitopes and/or other experimental or therapeutic molecules. The invention also encompasses polynucleotides encoding the localization signals and vectors comprising these polynucleotides.
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: March 31, 2015
    Assignee: Intrexon Corporation
    Inventor: Thomas David Reed
  • mTOR Ligands and Polynucleotides Encoding mTOR Ligands
    Publication number: 20140178931
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: February 24, 2014
    Publication date: June 26, 2014
    Applicant: Intrexon Corporation
    Inventors: Thomas David REED, Amy H. Aztel
  • Glycogen synthase kinase heteropolyligand polypeptide
    Patent number: 8729225
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate GSK3 activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: November 9, 2007
    Date of Patent: May 20, 2014
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • ERK Ligands and Polynucleotides Encoding ERK Ligands
    Publication number: 20140099668
    Abstract: The invention relates to kinase inhibitor ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate ERK activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: September 12, 2012
    Publication date: April 10, 2014
    Applicant: Intrexon Corporation
    Inventor: Thomas David REED
  • mTOR ligands and polynucleotides encoding mTOR ligands
    Patent number: 8679784
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: June 7, 2012
    Date of Patent: March 25, 2014
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • mTOR Ligands and Polynucleotides Encoding mTOR Ligands
    Publication number: 20130244329
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: June 7, 2012
    Publication date: September 19, 2013
    Applicant: Intrexon Corporation
    Inventors: Thomas David REED, Amy H. Atzel
  • Extracellular-signal-regulated-kinase (ERK) heteropolyligand polypeptide
    Patent number: 8283445
    Abstract: The invention relates to kinase inhibitor ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate ERK activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: November 8, 2007
    Date of Patent: October 9, 2012
    Assignee: Intrexon Corporation
    Inventor: Thomas David Reed
  • mTOR ligands and polynucleotides encoding mTOR ligands
    Patent number: 8211669
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: February 17, 2010
    Date of Patent: July 3, 2012
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • Tubulo-Vesicular Structure Localization Signals
    Publication number: 20110195504
    Abstract: The invention relates to polarized cell tubulo-vesicular structure localization signals. The localization signals are utilized as research tools or are linked to polypeptides of interest or therapeutic molecules. Disclosed are methods of making and using polypeptides and modified polypeptides as signals to localize therapeutics, experimental compounds, peptides, proteins and/or other macromolecules to the tubulo-vesicular structures of polarized cells. The polypeptides of the invention optionally include linkage to reporters, epitopes and/or other experimental or therapeutic molecules. The invention also encompasses polynucleotides encoding the localization signals and vectors comprising these polynucleotides.
    Type: Application
    Filed: December 20, 2010
    Publication date: August 11, 2011
    Applicant: Intrexon Corporation
    Inventor: Thomas David REED
  • mTOR Ligands and Polynucleotides Encoding mTOR Ligands
    Publication number: 20100257619
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: February 17, 2010
    Publication date: October 7, 2010
    Applicant: Intrexon Corporation
    Inventors: Thomas David REED, Amy H. Atzel
  • mTOR ligands and polynucleotides encoding mTOR ligands
    Patent number: 7705122
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: November 30, 2007
    Date of Patent: April 27, 2010
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel